{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:46:23Z","timestamp":1793709983449,"version":"4.6.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cca.2026.120991","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:51:08Z","timestamp":1774972268000},"page":"120991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["LC\u2013MS\/MS methods for synthetic opioids in urine: analytical and clinical evaluation"],"prefix":"10.1016","volume":"588","author":[{"given":"Selen","family":"Al","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aykut","family":"Kul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olcay","family":"Sagirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cca.2026.120991_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: an update","volume":"6","author":"Pathan","year":"2012","journal-title":"Br. J. Pain"},{"issue":"4","key":"10.1016\/j.cca.2026.120991_bb0010","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.toxac.2019.10.001","article-title":"Novel synthetic opioids: a review of the literature","volume":"31","author":"Salle","year":"2019","journal-title":"Toxicologie Analytique Et Clinique"},{"key":"10.1016\/j.cca.2026.120991_bb0015","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1016\/j.wneu.2021.03.065","article-title":"Effect of pethidine hydrochloride on the development of neural tube: a genetic analysis study in a chick embryo model","volume":"150","author":"Rakip","year":"2021","journal-title":"World Neurosurg."},{"issue":"8","key":"10.1016\/j.cca.2026.120991_bb0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/jat\/34.8.444","article-title":"Urine drug testing of chronic pain patients. III. Normetabolites as biomarkers of synthetic opioid use","volume":"34","author":"DePriest","year":"2010","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.cca.2026.120991_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.148","article-title":"Mechanism of opioid addiction and its intervention therapy: focusing on the reward circuitry and mu-opioid receptor","volume":"3","author":"Zhang","year":"2022","journal-title":"MedComm"},{"issue":"5","key":"10.1016\/j.cca.2026.120991_bb0030","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.3390\/molecules28052127","article-title":"LC-MS\/MS application in pharmacotoxicological field: current state and new applications","volume":"28","author":"D\u2019Ovidio","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.cca.2026.120991_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119995","article-title":"Clinical implications of opioid parent-metabolite ratios","volume":"565","author":"Liao","year":"2025","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.cca.2026.120991_bb0040","first-page":"286","article-title":"Opioid analgesics for nociceptive cancer pain: a comprehensive review","volume":"74","author":"Abdel Shaheed","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.cca.2026.120991_bb0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0963689718811060","article-title":"Historical review: opiate addiction and opioid receptors","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Transplant."},{"issue":"3","key":"10.1016\/j.cca.2026.120991_bb0050","doi-asserted-by":"crossref","first-page":"37517","DOI":"10.52965\/001c.37517","article-title":"Buprenorphine and its formulations: a comprehensive review","volume":"10","author":"Poliwoda","year":"2022","journal-title":"Health Psychol. Res."},{"issue":"1","key":"10.1016\/j.cca.2026.120991_bb0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13722-021-00244-8","article-title":"Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review","volume":"16","author":"Adams","year":"2021","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.cca.2026.120991_bb0060","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200544070-00001","article-title":"Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence","volume":"44","author":"Elkader","year":"2005","journal-title":"Clin. Pharmacokinet."},{"issue":"8","key":"10.1016\/j.cca.2026.120991_bb0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s40263-020-00743-3","article-title":"Methadone for pain management: a pharmacotherapeutic review","volume":"34","author":"Kreutzwiser","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.cca.2026.120991_bb0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5935\/1806-0013.20150012","article-title":"Revisiting methadone: pharmacokinetics, pharmacodynamics and clinical indication","volume":"16","author":"Barbosa Neto","year":"2015","journal-title":"Revista Dor"},{"issue":"12","key":"10.1016\/j.cca.2026.120991_bb0075","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jpain.2014.08.010","article-title":"The fentanyl story","volume":"15","author":"Stanley","year":"2014","journal-title":"J. Pain"},{"key":"10.1016\/j.cca.2026.120991_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104102","article-title":"Evaluation of fentanyl immunoassay test strips for rapid in-situ detection of fentanyl and fentanyl analogs in seized samples and alternative matrices","volume":"118","author":"Norman","year":"2023","journal-title":"Int. J. Drug Policy"},{"issue":"4","key":"10.1016\/j.cca.2026.120991_bb0085","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jat\/bkab021","article-title":"Determination of fentanyl, alpha-methylfentanyl, beta-hydroxyfentanyl and the metabolite norfentanyl in rat urine by LC\u2013MS-MS","volume":"46","author":"Li","year":"2022","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.cca.2026.120991_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00045391-200201000-00010","article-title":"Meperidine: A critical review","volume":"9","author":"Latta","year":"2002","journal-title":"Am. J. Ther."},{"issue":"6","key":"10.1016\/j.cca.2026.120991_bb0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/jat\/bkt043","article-title":"Simultaneous determination of pethidine and norpethidine in mouse plasma by liquid chromatography\u2013electrospray ionization source-mass spectrometry","volume":"37","author":"Zhang","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.cca.2026.120991_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115670","article-title":"An analytical approach to determining pethidine: an investigation of 18 patients urine","volume":"235","author":"Arslan","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.cca.2026.120991_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120414","article-title":"Nanosensing for tramadol detection: innovative opioid analysis","volume":"576","author":"Zeinaly","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.120991_bb0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2147\/JPR.S49502","article-title":"Review of extended-release formulations of tramadol for the management of chronic non-cancer pain: focus on marketed formulations","author":"Kizilbash","year":"2014","journal-title":"J. Pain Res."},{"issue":"1","key":"10.1016\/j.cca.2026.120991_bb0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1213\/ANE.0000000000001683","article-title":"Trends in tramadol: pharmacology, metabolism, and misuse","volume":"124","author":"Miotto","year":"2017","journal-title":"Anesth. Analg."},{"issue":"10182","key":"10.1016\/j.cca.2026.120991_bb0120","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: present status and future directions","volume":"393","author":"Blanco","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cca.2026.120991_bb0125","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.chc.2016.03.002","article-title":"Opioid use disorders","volume":"25","author":"Sharma","year":"2016","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.cca.2026.120991_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","article-title":"Opioid use disorder","volume":"6","author":"Strang","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cca.2026.120991_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-019-4751-4","article-title":"Opioid use disorder and treatment: challenges and opportunities","volume":"19","author":"Hoffman","year":"2019","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.cca.2026.120991_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cca.2018.02.034","article-title":"Monitoring opioid and benzodiazepine use and abuse: is oral fluid or urine the preferred specimen type?","volume":"481","author":"Petrides","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.120991_bb0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2014.06.023","article-title":"Evaluation of matrix effects using a spike recovery approach in a dilute-and-inject liquid chromatography\u2013tandem mass spectrometry opioid monitoring assay","volume":"437","author":"Mathias","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.120991_bb0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cca.2013.03.010","article-title":"Significant cost savings achieved by in-sourcing urine drug testing for monitoring medication compliance in pain management","volume":"422","author":"Melanson","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.120991_bb0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cca.2019.09.001","article-title":"Storage of urine specimens in point of care (POC) urine drug testing cups reduces concentrations of many drugs","volume":"499","author":"Haidari","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"1\u20132","key":"10.1016\/j.cca.2026.120991_bb0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0009-8981(01)00714-8","article-title":"Urine drug screening in the medical setting","volume":"315","author":"Hammett-Stabler","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.120991_bb0165","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cca.2013.09.039","article-title":"Utilization management in toxicology","volume":"427","author":"Zhang","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.120991_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113320","article-title":"Determination of pethidine of abuse and relevant metabolite norpethidine in urine by ultra-performance liquid chromatography-tandem mass spectrometry","volume":"186","author":"Kul","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"7","key":"10.1016\/j.cca.2026.120991_bb0175","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/1573412916999200627010536","article-title":"A rapid method for the determination of buprenorphine and norbuprenorphine in urine by UPLC-MS\/MS","volume":"17","author":"Kul","year":"2021","journal-title":"Curr. Pharm. Anal."},{"issue":"9","key":"10.1016\/j.cca.2026.120991_bb0180","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/jat\/bkz066","article-title":"LC-MS-MS vs ELISA: validation of a comprehensive urine toxicology screen by LC-MS-MS and a comparison of 100 forensic specimens","volume":"43","author":"Kahl","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.cca.2026.120991_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116075","article-title":"A multicomponent LC-MS\/MS method for drugs of abuse testing using volumetric DBS and a clinical evaluation by comparison with urine","volume":"243","author":"Guterstam","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.cca.2026.120991_bb0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/separations8020021","article-title":"ESI\u2013LC\u2013MS\/MS for therapeutic drug monitoring of binary mixture of pregabalin and tramadol: human plasma and urine applications","volume":"8","author":"Almalki","year":"2021","journal-title":"Separations"},{"issue":"1\u20133","key":"10.1016\/j.cca.2026.120991_bb0195","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.forsciint.2011.01.047","article-title":"Development and validation of a sensitive UPLC\u2013MS\/MS method for the analysis of narcotic analgesics in urine and whole blood in forensic context","volume":"215","author":"Verplaetse","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.cca.2026.120991_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2024.112354","article-title":"A comparative study of SPE-and DLLME-based methods for the determination of opioids and benzodiazepines in urine samples using LC\u2013MS\/MS","volume":"208","author":"Clivill\u00e9-Cabr\u00e9","year":"2025","journal-title":"Microchem. J."},{"key":"10.1016\/j.cca.2026.120991_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124303","article-title":"Identification of fentanyl analogs and potential biomarkers in urine using liquid chromatography-tandem mass spectrometry (LC-MS\/MS) and liquid chromatography-quadrupole\/time of flight mass spectrometry (LC-Q\/TOF-MS)","volume":"1247","author":"Schackmuth","year":"2024","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.cca.2026.120991_bb0210","series-title":"LC-MS in Drug Analysis: Methods and Protocols","first-page":"51","article-title":"Measurement of Buprenorphine and Norbuprenorphine in Urine","author":"Terrell","year":"2018"},{"key":"10.1016\/j.cca.2026.120991_bb0215","series-title":"Clinical Applications of Mass Spectrometry in Drug Analysis: Methods and Protocols","first-page":"69","article-title":"Quantitation of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, Norbuprenorphine Glucuronide, and Naloxone in Urine by LC-MS\/MS","author":"Marin","year":"2016"},{"issue":"3","key":"10.1016\/j.cca.2026.120991_bb0220","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/1556-4029.14674","article-title":"Quantification of methadone and its metabolites: EDDP and EMDP determined in autopsy cases using LC-MS\/MS","volume":"66","author":"Nowak","year":"2021","journal-title":"J. Forensic Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.120991_bb0225","article-title":"Short-cut route validated for monitoring fentanyl and its metabolite in urine using LC\u2013MS\/MS, in a wide concentration range","volume":"10","author":"Cavus Yonar","year":"2024","journal-title":"Future J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.cca.2026.120991_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/separations10060365","article-title":"Development and validation of liquid chromatography-tandem mass spectrometry method for simultaneous determination of tramadol and its phase i and II metabolites in human urine","volume":"10","author":"Chauhan","year":"2023","journal-title":"Separations"},{"key":"10.1016\/j.cca.2026.120991_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.greeac.2024.100115","article-title":"The use of deep eutectic solvent-liquid phase microextraction as green analytical sample treatment for the analysis of drugs in urine","volume":"9","author":"Garc\u00eda-Atienza","year":"2024","journal-title":"Green Anal. Chem."},{"issue":"2","key":"10.1016\/j.cca.2026.120991_bb0240","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/molecules29020335","article-title":"Developing and evaluating the greenness of a reliable, all-in-one thin-film microextraction protocol for determining fentanyl, methadone, and zolpidem in plasma, urine, and oral fluid","volume":"29","author":"Gory\u0144ski","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.cca.2026.120991_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcoa.2021.100006","article-title":"Quantitative analysis of fentanyl, several analogues and metabolites in urine by parallel artificial liquid membrane extraction and liquid chromatography tandem mass spectrometry analysis","volume":"1","author":"Vincenti","year":"2021","journal-title":"J. Chromatography Open"},{"key":"10.1016\/j.cca.2026.120991_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.461241","article-title":"Miniaturized extraction method for analysis of synthetic opioids in urine by microextraction with packed sorbent and liquid chromatography\u2014tandem mass spectrometry","volume":"1624","author":"da Cunha","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.cca.2026.120991_bb0255","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.chroma.2015.03.064","article-title":"Determination of co-administrated opioids and benzodiazepines in urine using column-switching solid-phase extraction and liquid chromatography\u2013tandem mass spectrometry","volume":"1395","author":"Xiong","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.cca.2026.120991_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.463966","article-title":"Understanding mobile phase buffer composition and chemical structure effects on electrospray ionization mass spectrometry response","volume":"1696","author":"Brookhart","year":"2023","journal-title":"J. Chromatogr. A"},{"issue":"1\u20132","key":"10.1016\/j.cca.2026.120991_bb0265","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cccn.2004.07.007","article-title":"Determination of creatinine in urine by tandem mass spectrometry","volume":"350","author":"Hu\u0161kov\u00e1","year":"2004","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.cca.2026.120991_bb0270","first-page":"19","article-title":"Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry","volume":"30","author":"Pitt","year":"2009","journal-title":"The Clinical Biochemist Reviews"},{"issue":"11\u221212","key":"10.1016\/j.cca.2026.120991_bb0275","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.cca.2011.01.029","article-title":"A new automated urine fentanyl immunoassay: technical performance and clinical utility for monitoring fentanyl compliance","volume":"412","author":"Snyder","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.120991_bb0280","first-page":"1","article-title":"Investigation of commercially available recombinant and conventional \u03b2-glucuronidases to evaluate the hydrolysis efficiencies against o-glucuronides and n-glucuronides in urinary drug screening","author":"Namera","year":"2025","journal-title":"Forensic Toxicol."},{"issue":"1","key":"10.1016\/j.cca.2026.120991_bb0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/ph17010013","article-title":"Exploring enzymatic hydrolysis of urine samples for investigation of drugs associated with drug-facilitated sexual assault","volume":"17","author":"Skov","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cca.2026.120991_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115937","article-title":"Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS\/MS and its application in the clinical determination in patients with tumors associated with overactive bladder","volume":"240","author":"Lou","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.cca.2026.120991_bb0295","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/13880209.2024.2354341","article-title":"Comprehensive profiling of the chemical constituents in dayuanyin decoction using UPLC-QTOF-MS combined with molecular networking","volume":"62","author":"Peng","year":"2024","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.cca.2026.120991_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156796","article-title":"Precision strike strategy for liver diseases trilogy with Xiao-chai-Hu decoction: a meta-analysis with machine learning","volume":"142","author":"Wang","year":"2025","journal-title":"Phytomedicine"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126001737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126001737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:47:05Z","timestamp":1778892425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126001737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":60,"alternative-id":["S0009898126001737"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.120991","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LC\u2013MS\/MS methods for synthetic opioids in urine: analytical and clinical evaluation","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.120991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120991"}}